A detailed history of Bridgefront Capital, LLC transactions in Zai Lab LTD stock. As of the latest transaction made, Bridgefront Capital, LLC holds 11,303 shares of ZLAB stock, worth $327,787. This represents 0.11% of its overall portfolio holdings.

Number of Shares
11,303
Holding current value
$327,787
% of portfolio
0.11%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$24.61 - $33.18 $278,166 - $375,033
11,303 New
11,303 $296,000
Q3 2021

Nov 12, 2021

SELL
$105.0 - $178.37 $159,495 - $270,944
-1,519 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$125.11 - $180.0 $190,042 - $273,420
1,519 New
1,519 $269,000

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.84B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Bridgefront Capital, LLC Portfolio

Follow Bridgefront Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgefront Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgefront Capital, LLC with notifications on news.